Kohjin Bio Co., Ltd.
177A.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.17B
Close$
Share Statistics
| Market cap | $4.17 Billion |
|---|---|
| Enterprise Value | $3.62 Billion |
| Dividend Yield | $10.00 (1.23%) |
| Earnings per Share | $49.11 |
| Beta | 0 |
| Outstanding Shares | 5,111,600 |
Return
| Return on Equity | 2.16% |
|---|---|
| Return on Assets | 1.44% |
| Return on Invested Capital | 2.95% |
Valuation & Multiples
| P/E Ratio | 32.85 |
|---|---|
| PEG | -21.74 |
| Price to Sales | 0.89 |
| Price to Book Ratio | 0.71 |
| Enterprise Value to Revenue | 0.77 |
| Enterprise Value to EBIT | 19.12 |
| Enterprise Value to Net Income | 28 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 0.31 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kohjin Bio Co., Ltd.
176 employees
CEO: Takahito Nakamura Kohjin Bio Co., Ltd., established in 1981 in Sakado, Japan, and known as Kohjin Co.,Ltd. until its rebranding in 1989, is a diversified life science enterprise. The company's core business involves the production and sale of various biol...